Phase II trial of Gemzar plus paraplatin [carboplatin] (plus Herceptin [trastuzumab] in HER2+ [human epidermal growth factor receptor-2 positive] patients) in metastatic breast cancer.
Phase of Trial: Phase II
Latest Information Update: 03 Feb 2010
At a glance
- Drugs Carboplatin; Gemcitabine; Trastuzumab
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 17 Dec 2009 Actual end date changed from Apr 2006 to Oct 2008 as reported by ClinicalTrials.gov.
- 28 Aug 2006 Status change